Blood Borne Articles & Analysis
-
EPA Approves Experimental Use Permit for Field Testing of Genetically Modified Aedes aegypti Mosquitos
On May 1, 2020, the U.S. Environmental Protection Agency granted an experimental use permit (EUP) to Oxitec Ltd. (Oxitec) to field test the use of genetically engineered Aedes aegypti mosquitoes as a way to reduce populations that serve as a vector for a variety of diseases including Zika virus. The EUP is designed to test the effectiveness of genetically engineered Aedes aegypti mosquitoes as a ...
-
OSHA Announces New Hazards for the Healthcare Industry
Last month, OSHA announced that agency investigators would increase their focus on a set of new key hazards for the healthcare industry during upcoming inspections. These hazards will aim to address musculoskeletal disorders related to patient or resident handling; blood borne pathogens; workplace violence; tuberculosis and slips, trips and falls. To those in the healthcare industry, this ...
-
CIHs Qualified to Assist with Ebola Outbreak
This year, the largest Ebola epidemic in history occurred in multiple countries across West Africa. In September, a person who traveled from Africa to the United States was diagnosed with the condition in Texas. The virus then spread to several healthcare workers who provided the patient with medical care. Others who offered medical care in West Africa have also become infected and have been ...
-
Velano raises $15M to go beyond non-invasive blood tests
For most of us, getting blood drawn is an unpleasant, but necessary, part of life. For others, though, it’s extremely risky, if not impossible. Those people have what is known as difficult venous access (DVA), and they can include children, people witjh chronic illnesses, the elderly and people with diabetes, among others. Velano Vascular is a company that has developed a way to draw blood ...
-
Hummingbird Diagnostics Announces Publication of Study on the Utility of miRisk, a Blood-based microRNA Analysis, to Predict Overall Survival for Advanced Non-Small Cell Lung Cancer in npj Precision Oncology
Results describe development of analysis to uncover association of several microRNAs with overall survival following initiation of immunotherapy. Blood-based test holds potential for broad applicability for the management of patients with cancer. Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today announced the ...
-
Novosanis launches Colli-Pee containing UAS Large Volumes, offering a new solution for oncology research
Today, Novosanis has launched its novel solution for oncology research applications. Together with our sister company DNA Genotek, we have developed a novel stabilization chemistry, UAS, for the preservation of extracellular vesicle (EV) RNA, and cell-free DNA (cfDNA) in urine, collected with Colli-Pee. Novosanis hereby offers a solution for applications in the field of oncology research and ...
By Novosanis NV
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you